Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Osteoarthritis Drugs Market

Osteoarthritis Drugs Market Trends

Report ID: GMI8580
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Osteoarthritis Drugs Market Trends

The market growth is owing to increasing elderly population base that are more prone to osteoarthritis. For instance, as highlighted in a PubMed Central article from September 2022, osteoarthritis stands out as a leading cause of disability, affecting nearly 10% of the global population aged 60 years and older. This rise in the geriatric population has led to a greater focus on geriatric healthcare, including the development of specialized treatments and medications tailored to the needs of older patient.
Thus, pharmaceutical companies are investing in research and development efforts to create innovative therapies that address the unique challenges of treating osteoarthritis in elderly patients, thereby fostering the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gas analyzer systems market in North America was reached USD 976.2 million in 2023 and is projected to record a CAGR of 5.3% through 2032, driven by the increasing adoption of online continuous monitoring systems and stringent environmental regulations aimed at reducing air pollution and emissions.

Electrochemical gas analyzer systems segment held a dominant market share in 2023 in North America and is poised to cross USD 460 million by 2032, driven by escalating emission levels across diverse end-use sectors.

U.S. gas analyzer systems industry surpass USD 1.10 billion by 2032, driven by the growing emphasis on improving industrial processes' efficiency and safety, along with technological advancements, particularly in sensor technology and data analytics.

ABB, Acoem., AMETEK. Inc., AVL, Dragerwerk AG & Co.KGaA, DURAG GROUP, Emerson ElectricCo.,ENVEA, Figaro Engineering Inc., General Electric, Honeywell International Inc are some of the major industry contenders.